Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
1.340
-0.160 (-10.67%)
At close: Dec 20, 2024, 4:00 PM
1.360
+0.020 (1.49%)
After-hours: Dec 20, 2024, 7:59 PM EST
RVPH Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 45 | 144 | 87 | 40 | 81 | 27 | |
| Market Cap Growth | -56.89% | 65.49% | 115.01% | -49.95% | 195.66% | 6.77% | |
| Enterprise Value | 39 | 139 | 64 | 7 | 114 | 32 | |
| Last Close Price | 1.34 | 5.15 | 4.25 | 2.89 | 8.74 | 10.46 | |
| PB Ratio | -4.77 | 25.14 | 10.35 | 1.41 | 14.77 | -4.01 | |
| P/TBV Ratio | - | 25.14 | 10.35 | 1.41 | 14.77 | - | |
| Debt / Equity Ratio | -0.01 | - | - | - | - | -0.55 | |
| Quick Ratio | 0.32 | 1.36 | 1.86 | 12.66 | 6.57 | 0.00 | |
| Current Ratio | 0.39 | 1.38 | 1.90 | 13.39 | 6.57 | 0.00 | |
| Return on Equity (ROE) | - | -556.38% | -152.43% | -49.91% | - | - | |
| Return on Assets (ROA) | -327.78% | -115.85% | -70.11% | -31.45% | -34.72% | -379.02% | |
| Return on Capital (ROIC) | - | -349.89% | -95.16% | -36.98% | -125.79% | - | |
| Earnings Yield | -73.67% | -27.31% | -32.53% | -21.09% | -4.69% | -3.10% | |
| FCF Yield | -74.36% | -19.70% | -21.82% | -26.40% | -5.04% | -0.80% | |
| Buyback Yield / Dilution | -35.27% | -21.94% | -31.95% | -383.10% | -10.60% | - | |
| Total Shareholder Return | -35.27% | -21.94% | -31.95% | -383.10% | -10.60% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.